Impact of medical therapy on transurethral resection of the prostate: a decade of change.

摘要: Abstract Objectives. To assess whether medical therapy has delayed the need for eventual transurethral prostatectomy (TURP), causing a shift in population characteristics of men undergoing TURP (ie, older, more comorbidities, advanced disease), resulting complications and poorer outcomes. The introduction symptomatic benign prostatic hyperplasia (BPH) during past decade may have changed indications TURP. Methods. All patients who underwent BPH at our institution 1988 (before general BPH) 1998 (medical primary initial were reviewed. We compared two groups with respect to total number TURPs, surgery, patient age, health status, weight resected tissue, preoperative postoperative complications. Results. Despite 16% increase risk BPH-related events, 60% decrease TURPs performed occurred (n = 64) 10 years earlier 157). No significant difference was found age between groups, no comorbid status observed. Previous management had failed 36% required 1998. A significantly higher percentage presented acute urinary retention (55%) upper tract obstructive uropathy (12.5%) (23% 1.3% uropathy). Patients healthier, smaller resections, their catheters removed earlier, discharged home earlier. Although they likely be catheter situ, observed incidence Conclusions. There been dramatic since advent therapy. proportion presenting hydronephrosis increased, but average operative parameters, not changed.